Reversal of scopolamine-induced amnesia of passive avoidance by pre- and post-training naloxone

Psychopharmacology - Tập 89 - Trang 296-300 - 1986
Douglas K. Rush1
1Cassella AG, Department of Pharmacology, CNS Research, Frankfurt 61, Federal Republic of Germany

Tóm tắt

In a series of five experiments, the modulating role of naloxone on a scopolamine-induced retention deficit in a passive avoidance paradigm was investigated in mice. Scopolamine, but not methyl scopolamine (1 and 3 mg/kg), induced an amnesia as measured by latency and duration parameters. Naloxone (0.3, 1, 3, and 10 mg/kg) injected prior to training attenuated the retention deficit with a peak of activity at 3 mg/kg. The effect of naloxone could be antagonized with morphine (1, 3, and 10 mg/kg), demonstrating the opioid specificity of the naloxone effect. Post-training administration of naloxone (3 mg/kg) as a single or as a split dose also attenuated the scopolamine-induced amnesia. Control experiments indicated that neither an increase in pain sensitivity (pre-training naloxone) nor an induced aversive state (post-training naloxone) appear to be responsible for the influence of naloxone on the scopolamine-induced retention deficit. These results extend previous findings implicating a cholinergic-opioid interaction in memory processes. A possible mechanism for this interaction involving the septo-hippocampal cholinergic pathway is discussed.

Tài liệu tham khảo

Arendt T, Bigl V, Arendt A, Tennstedt A (1983) Loss of neurons in the nucleus basalis of Meynert in Alzheimer's disease, paralysis agitans and Korsakoff's disease. Acta Neuropathol 61:101–108 Ball MJ, Hachinski V, Fox A, Kirshen AJ, Fisman M, Blume W, Kral VA, Fox H, Merskey H (1985) A new definition of Alzheimer's disease: a hippocampal dementia. Lancet i:14–16 Baratti CM, Introini IB, Huygens P (1984) Possible interaction between central cholinergic muscarinic and opioid peptidergic systems during memory consolidation in mice. Behav Neural Biol 40:155–169 Blaker WD, Peruzzi G, Costa E (1984) Behavioral and neurochemical differentiation of specific projections in the septo-hippocampal cholinergic pathway of the rat. Proc Natl Acad Sci USA 81:1880–1882 Botticelli LJ, Wurtman RJ (1982) Septohippocampal cholinergic neurons are regulated trans-synaptically by endorphin and corticotropin neuropeptides. J Neurosci 9:1316–1321 Caine ED, Weingartner H, Ludlow CL, Cudahy EA, Wehry S (1981) Qualitative analysis of scopolamine-induced amnesia. Psychopharmacology 74:74–80 Carrasco MA, Dias RD, Izquierdo I (1982) Naloxone reverses retrograde amnesia induced by electroconvulsive shock. Behav Neural Biol 34:352–357 Coyle JT, Price DL, DeLong MR (1983) Alzheimer's disease: a disorder of cortical cholinergic innervation. Science 219:1184–1190 Ennis C, Wyllie MG (1984) Evidence for functionally distinct μ receptors modulating acetylcholine release. Neuropeptides 5:109–112 Fulginiti S, Cancela LM (1983) Effect of naloxone and amphetamine on acquisition and memory consolidation of active avoidance responses in rats. Psychopharmacology 79:45–48 Gallagher M, King RA, Young NB (1983) Opiate antagonists improve spatial memory. Science 221:975–976 Garzon J, Rubio J, del Rio J (1981) Naloxone blocks the effect of 5-hydroxy-tryptophan on passive avoidance learning in rats: implication of endogenous opioid peptides. Life Sci 29:17–25 Glick SD, Zimmerberg B (1972) Amnesic effects of scopolamine. Behav Biol 7:245–254 Gold PE, McGaugh JL (1975) A single-trace two-process view of memory storage processes. In: Deutsch D, Deutsch JA (eds) Short-term memory. Academic Press, New York, 355–378 Gold PE, Zornetzer SF (1983) The mnemon and its juices: neuromodulation of memory processes. Behav Neural Biol 38:151–189 Gottfries CG (1985) Alzheimer's disease and senile dementia: biochemical characteristics and aspects of treatment. Psychopharmacology 86:245–252 Gray JA, McNaughton N (1983) Comparison between the behavioural effects of septal and hippocampal lesions: a review. Neurosci Biobehav Rev 7:119–188 Hamilton LW, McCleary RA, Grossman SP (1968) Behavioral effects of cholinergic septal blockade in the cat. J Comp Physiol Psychol 66:563–568 Introini IB, Baratti CM (1984) The impairment of retention induced by β-endorphin in mice may be mediated by a reduction of central cholinergic activity. Behav Neural Biol 41:152–163 Izquierdo I (1979) Effect of naloxone and morphine on various forms of memory in the rat: possible role of endogenous opiate mechanism in memory consolidation. Psychopharmacology 66:199–203 Izquierdo I, Souza DO, Dias RD, Perry MLS, Carrasco MA, Volkmer N, Netto CA (1984) Effect of various behavioral training and testing procedures on brain β-endorphin-like immunoreactivity and the possible role of β-endorphin in behavioral regulation. Psychoneuroendocrinology 9:381–389 Jensen RA, Messing RB, Spiehler VR, Martinez JL Jr, Vasquez BJ, McGaugh JL (1980) Memory, opiate receptors, and aging. Peptides 1 (Suppl. 1): 197–201 Jhamandas K, Sutak M (1983) Stereospecific enhancement of evoked release of brain acetylcholine by narcotic antagonists. Br J Pharmacol 78:433–440 Johns CA, Haroutunian V, Greenwald BS, Mohs RC, Davis DM, Kanof P, Horvath TB, Davis KL (1985) Development of cholinergic drugs for the treatment of Alzheimer's disease. Drug Dev Res 5:77–96 Kirk RE (1968) Experimental design: Procedures for the behavioral sciences. Brooks/Cole, Belmont, California Khachaturian H, Lewis ME, Schäfer MK, Watson SJ (1985) Anatomy of the CNS opioid systems. Trends Neurosci 8:111–119 Messing RB, Jensen RA, Martinez JL Jr, Spiehler VR, Vasquez BJ, Soumireu-Mourat B, Liang KC, McGaugh JL (1979) Naloxone enhancement of memory. Behav Neural Biol 27:266–275 Mohs RC, Davis KL (1985) Interaction of choline and scopolamine in human memory. Life Sci 37:193–197 Moroni F, Cheney DL, Costa E (1978) The turnover rate of acetylcholine in brain nuclei of rats injected intraventricularly and intraseptally with alpha and beta-endorphin. Neuropharmacology 17:191–196 Mucha RF, Millan MJ, Herz A (1985) Aversive properties of naloxone in non-dependent (naive) rats may involve blockade of central β-endorphin. Psychopharmacology 86:281–285 Netto CA, Cavalheiro EA, Carrasco MS, Volkmer N, Dias RD, Izquierdo I (1985) Response of the rat brain β-endorphin system to novelty: importance of the fornix connection. Behav Neural Biol 43:37–46 Okajima T, Ikuyama S, Kato K, Ibayashi H (1984) Naloxone inhibits the plama epinephrine response to ACTH but not to 2-deoxy-d-glucose in rats. Life Sci 35:2177–2181 Panella JJ, Blass JP (1984) Lack of clinical benefit from naloxone in a dementia day hospital. Ann Neurol 15:308 Reisberg B, Ferris SH, Anand R, Mir P, Geibel V, DeLeon MJ, Roberts E (1983) Effects of naloxone in senile dementia: a double-blind trial. N Engl J Med 308:721–722 Weiner NI, Messer J (1973) Scopolamine-induced impairment of long-term retention in rats. Behav Biol 9:227–234 Woolf NJ, Eckenstein F, Butcher LL (1984) Cholinergic systems in the rat brain: I. Projections to the limbic telencephalon. Brain Res Bull 13:751–784 Zwick R, Marascuilo LA (1984) Selection of pairwise multiple comparison procedures for parametric and nonparametric analysis of variance models. Psychol Bull 95:148–155